Insider Transactions in Q4 2023 at Eagle Pharmaceuticals, Inc. (EGRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
452
-0.94%
|
$1,808
$4.76 P/Share
|
|
Nov 02
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
10,694
-1.92%
|
$139,022
$13.87 P/Share
|
|
Nov 01
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
10,925
-1.93%
|
$142,025
$13.82 P/Share
|
|
Oct 27
2023
|
Michael Graves Interim Executive Chair & PEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,360
+47.46%
|
$37,440
$4.94 P/Share
|
|
Oct 03
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
10,734
-0.93%
|
$150,276
$14.76 P/Share
|
|
Oct 02
2023
|
Scott Tarriff |
SELL
Open market or private sale
|
Direct |
9,511
-1.62%
|
$142,665
$15.23 P/Share
|